Alcobra Ltd (ADHD.OQ)

ADHD.OQ on NASDAQ Stock Exchange Global Market

5.60USD
5 May 2015
Change (% chg)

-- (--)
Prev Close
$5.60
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
39,654
52-wk High
$22.14
52-wk Low
$3.13

ADHD.OQ

Chart for ADHD.OQ

About

Alcobra Ltd is an Israel-based Biopharmaceutical company. It focuses on the development and commercialization of a proprietary drug, MG01CI, to treat Attention Deficit Hyperactivity Disorder (ADHD), a common and morbid neuropsychiatric condition in children and adults. Adult ADHD is associated with increased health risks and... (more)

Overall

Beta: --
Market Cap(Mil.): $118.81
Shares Outstanding(Mil.): 21.18
Dividend: --
Yield (%): --

Financials

  ADHD.OQ Industry Sector
P/E (TTM): -- 188.47 40.23
EPS (TTM): -2.40 -- --
ROI: -95.68 -0.64 15.26
ROE: -95.68 -2.50 16.08
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: ValuEngine, Inc.
$49.00
Provider: Pechala's Reports
$1,000.00
Provider: Zacks Investment Research Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks